Cargando…
Immune‐viral dynamics modeling for SARS‐CoV‐2 drug development
Coronavirus disease 2019 (COVID‐19) global pandemic is caused by severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2) viral infection, which can lead to pneumonia, lung injury, and death in susceptible populations. Understanding viral dynamics of SARS‐CoV‐2 is critical for development of eff...
Autores principales: | Cao, Youfang, Gao, Wei, Caro, Luzelena, Stone, Julie A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444857/ https://www.ncbi.nlm.nih.gov/pubmed/34121337 http://dx.doi.org/10.1111/cts.13099 |
Ejemplares similares
-
523. Use of Immune-Viral Dynamics Modeling to Understand Molnupiravir Drug Effect for COVID-19
por: Cao, Youfang, et al.
Publicado: (2021) -
Modeling the viral dynamics of SARS-CoV-2 infection
por: Wang, Sunpeng, et al.
Publicado: (2020) -
Viral dynamics of SARS-CoV-2 in immunocompromised patients
por: Utzon, Andrea N., et al.
Publicado: (2023) -
SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis
por: Cevik, Muge, et al.
Publicado: (2021) -
Initiation of Antiviral Treatment in SARS‐CoV2: Modeling Viral Dynamics and Drug Properties
por: Rosenbloom, Daniel Scholes, et al.
Publicado: (2020)